Select your language
The Abraaj Group, a leading investor operating in global growth markets, has announced its full exit from Tunisian pharmaceutical company Opalia Pharma S.A. The Group has sold its entire stake to Recordati, an international pharmaceutical company listed on the Italian stock exchange.
Tunisia's Central Bank today held its benchmark interest rate at 4 percent. Considering improvement of economic activity over the third quarter of the current year in industrialized countries, and positive indicators in the national economic situation.
Page 9 of 9
 | BRVM-CI | 274.38 | +0.01% | 20/12 |
 | BSE DCI | 10,049.11 | - | 20/12 |
 | DSE ASI | 2,120.80 | +0.66% | 20/12 |
 | EGX 30 | 30,372.70 | -0.50% | 22/12 |
 | GSE-CI | 4,854.04 | +0.92% | 20/12 |
 | JSE ASI | 84,603.31 | +0.16% | 20/12 |
 | LuSE ASI | 15,571.03 | -0.09% | 20/12 |
 | MASI | 14,721.45 | -0.02% | 20/12 |
 | MSE ASI | 169,838.19 | -0.01% | 20/12 |
 | NGX ASI | 101,129.09 | -0.12% | 20/12 |
 | NSE ASI | 121.72 | +0.31% | 20/12 |
 | NSX OI | 1,787.64 | -0.75% | 20/12 |
 | RSE ASI | 148.60 | - | 20/12 |
 | SEM ASI | 2,138.06 | +0.07% | 20/12 |
 | TUNINDEX | 9,884.50 | -0.08% | 20/12 |
 | USE ASI | 1,159.11 | -1.06% | 20/12 |
 | ZSE ASI | 215.54 | +1.33% | 20/12 |
FR 
